BRAF and neuroendocrine carcinoma: Furthermore, the lower rates of BRAF mutations in some of these small cohorts of well-differentiated GEP-NENs suggest that BRAF mutations may be more frequent in NEC compared to lower-grade NETs of GI or pancreas origin [28, 29].